Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 24.15
+0.10 (0.42%)
Apr 2, 2026, 1:30 PM CST
TPEX:4139 Revenue
In the year 2025, Ma Kuang Healthcare Holding had annual revenue of 1.09B TWD, down -3.34%. Ma Kuang Healthcare Holding had revenue of 290.83M in the quarter ending December 31, 2025, a decrease of -3.88%.
Revenue
1.09B
Revenue Growth
-3.34%
P/S Ratio
0.99
Revenue / Employee
n/a
Employees
466
Market Cap
1.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.09B | -37.75M | -3.34% |
| Dec 31, 2024 | 1.13B | -87.85M | -7.21% |
| Dec 31, 2023 | 1.22B | 159.37M | 15.05% |
| Dec 31, 2022 | 1.06B | 99.29M | 10.35% |
| Dec 31, 2021 | 959.45M | 49.21M | 5.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Anxo Pharmaceutical | 883.22M |
| Prince Pharmaceutical | 798.27M |
| Level Biotechnology | 736.59M |
| Wiltrom | 311.77M |
| GeneReach Biotechnology | 232.74M |